Deferasirox
- Product NDC
- 0093-3515
- 11-digit product format
- 000933515
- Labeler code
- 0093
- Product ID
- 0093-3515_5c7e5e3c-67ce-4a08-afc2-ce9709c7cc6d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferasirox
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA209223
- Marketing category
- ANDA
- Marketing start
- 2019-11-25
- Marketing end
- 2021-10-31
- Substance
- DEFERASIROX
- Active strength
- 360 mg/1
- Pharmacologic classes
- Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3515-56 | 00093351556 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-3515-56) | 2019-11-25 | 2021-10-31 | No | No | Current |